Bone Biologics annual shareholder meeting confirms four directors
Bone Biologics held its annual shareholder meeting on Sept. 28, 2026. Shareholders confirmed four director nominees, ratified Weinberg & Company, P.A. as independent auditor for the year ending Dec. 31, 2026, and approved potential issuance of common shares underlying certain warrants tied to a July 7, 2026 agreement.